tiprankstipranks
COSMOS Pharmaceutical Corporation (JP:3349)
:3349
Japanese Market
3349
COSMOS Pharmaceutical Corporation
RESEARCH TOOLSreports
Want to see JP:3349 full AI Analyst Report?

COSMOS Pharmaceutical Corporation (3349) Financial Statements

1 Followers

COSMOS Pharmaceutical Corporation Financial Overview

COSMOS Pharmaceutical Corporation's market cap is currently ¥508.09B. The company's EPS TTM is ¥404.32; its P/E ratio is 15.79; and it has a dividend yield of 1.28%. COSMOS Pharmaceutical Corporation is scheduled to report earnings on July 13, 2026, and the estimated EPS forecast is ¥105.98. See an overview of income statement, balance sheet, and cash flow financials.
May 26May 25May 24May 23May 22
Income Statement
Total Revenue¥ 1.10T¥ 1.01T¥ 964.99B¥ 827.70B¥ 755.41B
Gross Profit¥ 229.68B¥ 213.28B¥ 188.31B¥ 168.72B¥ 151.45B
Operating Income¥ 42.35B¥ 40.40B¥ 31.50B¥ 30.13B¥ 29.80B
EBITDA¥ 66.93B¥ 64.85B¥ 53.74B¥ 50.19B¥ 48.21B
Net Income¥ 32.05B¥ 30.98B¥ 24.45B¥ 23.80B¥ 23.16B
Balance Sheet
Cash & Short-Term Investments¥ 61.34B¥ 57.04B¥ 52.30B¥ 45.93B¥ 37.36B
Total Assets¥ 596.49B¥ 525.17B¥ 476.98B¥ 421.41B¥ 363.50B
Total Debt¥ 78.48B¥ 49.96B¥ 34.06B¥ 18.20B¥ 9.41B
Net Debt¥ 17.14B¥ -7.08B¥ -18.24B¥ -27.73B¥ -27.95B
Total Liabilities¥ 312.78B¥ 267.71B¥ 245.53B¥ 210.33B¥ 172.99B
Stockholders' Equity¥ 283.70B¥ 257.46B¥ 231.44B¥ 211.07B¥ 190.51B
Cash Flow
Free Cash Flow¥ -11.67B¥ -859.00M¥ -859.00M¥ -635.00M¥ 7.80B
Operating Cash Flow¥ 58.79B¥ 52.47B¥ 52.47B¥ 55.17B¥ 54.43B
Investing Cash Flow¥ -81.90B¥ -55.45B¥ -55.45B¥ -57.33B¥ -49.11B
Financing Cash Flow¥ 19.32B¥ 7.72B¥ 7.72B¥ 8.53B¥ 3.25B
Currency in JPY

COSMOS Pharmaceutical Corporation Earnings and Revenue History

Income Statement >

COSMOS Pharmaceutical Corporation Debt to Assets

Balance Sheet >

COSMOS Pharmaceutical Corporation Cash Flow

Cash Flow >

COSMOS Pharmaceutical Corporation Forecast EPS vs Actual EPS

Earnings >